Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review
Clinical Colorectal Cancer · 2024
DOI: 10.1016/j.clcc.2024.01.004 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Colorectal Cancer, 2024. Verfasst von Eric D Miller und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Comprehen…. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH, National Institutes of Health.
Abstract (Originalsprache)
BACKGROUND: A survey of medical oncologists (MOs), radiation oncologists (ROs), and surgical oncologists (SOs) who are experts in the management of patients with metastatic colorectal cancer (mCRC) was conducted to identify factors used to consider metastasis-directed therapy (MDT). MATERIALS AND METHODS: An online survey to assess clinical factors when weighing MDT in patients with mCRC was developed based on systematic review of the literature and integrated with clinical vignettes. Supporting evidence from the systematic review was included to aid in answering questions. RESULTS: Among 75 experts on mCRC invited, 47 (response rate 62.7%) chose to participate including 16 MOs, 16 ROs, and 15 SOs. Most experts would not consider MDT in patients with 3 lesions in both the liver and lung regardless of distribution or timing of metastatic disease diagnosis (6 vs. 36 months after definitive treatment). Similarly, for patients with retroperitoneal lymph node and lung and liver involvement, most experts would not offer MDT regardless of timing of metastatic disease diagnosis. In general, SOs were willing to consider MDT in patients with more advanced disease, ROs were more willing to offer treatment regardless of metastatic site location, and MOs were the least likely to consider MDT. CONCLUSIONS: Among experts caring for patients with mCRC, significant variation was noted among MOs, ROs, and SOs in the distribution and volume of metastatic disease for which MDT would be considered. This variability highlights differing opinions on management of these patients and underscores the need for well-designed prospective randomized trials to characterize the risks and potential benefits of MDT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Comprehensive Cancer Center, Columbus, OH. Electronic address: Eric.Miller@osum…
- Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH.
- Department of Surgery, Division of Surgical Oncology at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
- Department of Radiation Oncology, City of Hope, Duarte, CA.
- Department of Radiation Oncology, University of Florida, Gainesville, FL.
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Förderung
- NIH
- National Institutes of Health
Zitieren
APA
Miller, E. D., Klamer, B. G., Cloyd, J. M., Pawlik, T. M., Williams, T. M., Hitchcock, K. E., Romesser, P. B., Mamon, H. J., Ng, K., Gholami, S., Chang, G. J., & Anker, C. J. (2024). Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review. Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2024.01.004
Vancouver
Miller ED, Klamer BG, Cloyd JM, Pawlik TM, Williams TM, Hitchcock KE, et al. Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review. Clinical Colorectal Cancer. 2024. doi:10.1016/j.clcc.2024.01.004
BibTeX
@article{Miller2024,
author = {Miller, Eric D and Klamer, Brett G and Cloyd, Jordan M and Pawlik, Timothy M and Williams, Terence M and Hitchcock, Kathryn E and Romesser, Paul B and Mamon, Harvey J and Ng, Kimmie and Gholami, Sepideh and Chang, George J and Anker, Christopher J},
title = {Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review},
journal = {Clinical Colorectal Cancer},
year = {2024},
doi = {10.1016/j.clcc.2024.01.004}
}
EUVIMED